Elanco Animal Health (ELAN) Net Cash Flow Growth (3y) (2020 - 2026)
Powered by 
Analysis
Elanco Animal Health (ELAN) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.46 Bn | 40.26 Bn | 779.09 Mn | -29.30% |
| 2 | Zoetis | 30.65 Bn | 28.98 Bn | 1.05 Bn | -5.41% |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn | 17.73% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 18.48% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 75.29 Mn | 68.19 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -217.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.73% |
| Mar 31, 2026 | -62.71% |
| Dec 31, 2025 | 29.60% |
| Sep 30, 2025 | -27.22% |
| Jun 30, 2025 | -48.12% |
| Mar 31, 2025 | 67.49% |
| Dec 31, 2024 | -34.19% |
| Sep 30, 2024 | 36.54% |
| Jun 30, 2024 | 9.09% |
| Mar 31, 2024 | -29.33% |
| Dec 31, 2023 | 54.87% |
| Sep 30, 2023 | 26.13% |
| Jun 30, 2023 | -31.58% |
| Mar 31, 2023 | -26.61% |
| Dec 31, 2022 | -73.75% |
| Sep 30, 2022 | 43.08% |
| Jun 30, 2022 | 24.26% |
| Mar 31, 2022 | 7.05% |
| Dec 31, 2021 | 39.46% |
| Sep 30, 2021 | -30.14% |